SCHEMBL30134236

SCHEMBL30134236

CC(=O)c1ccc2c(c1)C(F)(F)CCO2

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.53
RARA P10276 5/20 0.47
RARB P10826 5/20 0.47
RARG P13631 5/20 0.47
RXRA P19793 1/20 0.44
CYP26A1 O43174 1/20 0.41
CYP26B1 Q9NR63 1/20 0.41
AKR1B1 P15121 2/20 0.41
PDK2 Q15119 1/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
BRAF P15056 1/20 0.40
KDR P35968 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ATM Q13315 1/20 0.39
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30353262 0.83 KDM4E (0.54) KDM4ERARARARBRARGRXRA
SCHEMBL2240683 0.83 RARB (0.64) KDM4ERARARARBRARGRXRA
SCHEMBL4421853 0.79 KDM4E (0.50) KDM4ERARARARBRARGRXRA
SCHEMBL11926956 0.76 BACE1 (0.42) AKR1B1MAPT
SCHEMBL7681598 0.75 KDM4E (0.46) KDM4ERARARARBRARGRXRA
SCHEMBL29249340 0.75 RARB (0.61) RARARARBRARGRXRACYP26A1
SCHEMBL29249339 0.75 RARB (0.61) RARARARBRARGRXRACYP26A1
SCHEMBL13668239 0.74 KDM4E (0.50) KDM4ERARARARBRARGRXRA
SCHEMBL9144307 0.74 KDM4E (0.54) KDM4ERARARARBRARGRXRA
SCHEMBL102971 0.73 KDM4E (0.89) KDM4ENPC1MAPTRAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125378-A2 Heterocyclic Compounds BEONE MEDICINES I GMBH (CH) 2026-05-07 US disclosed
EP-4658650-A1 HETEROCYCLIC COMPOUNDS Beone Medicines I GmbH (CH) 2025-12-10 EP disclosed
US-20250353846-A1 Heterocyclic Compounds BEONE MEDICINES I GMBH (CH) 2025-11-20 US disclosed
CN-119119033-A Pyrazolopyridone compounds 百济神州有限公司 2024-12-13 CN disclosed
US-20240300951-A1 Pyrazolopyridinone Compounds BEIGENE LTD. (KY) 2024-09-12 US disclosed
US-20240270751-A1 Pyrazolopyridinone Compounds BEIGENE LTD. (KY) 2024-08-15 US disclosed
WO-2024160277-A1 HETEROCYCLIC COMPOUNDS BEIGENE, LTD. (KY) 2024-08-08 WO disclosed
EP-4380936-A1 PYRAZOLOPYRIDINONE COMPOUNDS BeiGene, Ltd. (KY) 2024-06-12 EP disclosed
CN-117836296-A Pyrazolopyridone compounds 百济神州有限公司 2024-04-05 CN disclosed
WO-2023011456-A1 PYRAZOLOPYRIDINONE COMPOUNDS BEIGENE, LTD. (KY) 2023-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125378-A2 Heterocyclic Compounds NFATC1, CD4, MALT1 KDM4E 1832/4885RARA 722/4885RARB 325/4885
US-20250353846-A1 Heterocyclic Compounds NFATC1, CD4, ACIN1 KDM4E 2752/4885RARA 694/4885RARB 564/4885
US-20240300951-A1 Pyrazolopyridinone Compounds NFATC1, CD4, PBK KDM4E 2009/4885RARA 1913/4885RARB 1456/4885
US-20240270751-A1 Pyrazolopyridinone Compounds NFATC1, CD4, PBK KDM4E 2009/4885RARA 1913/4885RARB 1456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.